NexLife review (2026): pricing, programs, pros & limitations

Provider snapshot

NexLife pricing and what is included

Every NexLife program

NexLife publishes six programmes at four plan lengths each. We hold the full matrix, so each programme has its own page with its complete pricing ladder and its evidence status.

How NexLife prices against the field

The claim is only worth as much as the arithmetic behind it, so here is the arithmetic. Every full-dose compounded tirzepatide programme we track, sorted by what you actually pay each month.

Where NexLife does not win

A recommendation without limits is an advertisement. These are the real ones.

• Found beats it on price for full-dose tirzepatide — $169 vs $186 — if you prepay 12 months (~$2,028 up front).
• Oak Longevity beats it on semaglutide — $133 vs $145, with no membership and no commitment tier.
• The $147 and $186 rates require a 12-month commitment. Month-to-month is $215.
• No brand pathway. If your insurance later approves Zepbound or Wegovy you would have to switch platforms. Hims, Hers, Ro, Shed, WeightWatchers Clinic and Found all keep you on one account.
• No insurance coordination. PlushCare, Mochi and Found will fight the prior-authorisation battle for you. NexLife is cash-pay.
• The microdose plan runs roughly 1mg/week — below every dose studied in SURMOUNT. Same caveat applies to every microdose programme.
• Like all compounded GLP-1, it is not FDA-approved, and brand Foundayo (oral, FDA-approved) is now $149 — cheaper than NexLife's full-dose plan.
• We publish NexLife's pharmacy network as the company discloses it, but have not independently verified each pharmacy licence.

Does it still beat the brand?

This is the question that now decides whether any compounded programme is worth using at all — because brand Zepbound has fallen to $299 at the starting dose. NexLife at $186 clears that floor by $113/month. Several competitors do not clear it at all.

Medical oversight

A legitimate GLP-1 program requires a licensed clinician to review the patient's history before any prescription. Medical Director: Adam Kennah, MD (NPI 1144260043, provider-supplied). Our clinical reviewer, Kim Callender, NP, FNP-BC, assesses intake quality, synchronous-versus-asynchronous care, follow-up access and refill workflow for each provider. Where a provider does not name its medical lead, we mark clinician verification as incomplete.

Pharmacy and sourcing

Pharmacy transparency is one of the strongest legitimacy signals. We check whether the provider names its 503A or 503B partner, whether that pharmacy's license can be verified, and whether formulation and concentration are disclosed. For NexLife: Network disclosed: Red Rock, Hallandale, Absolute, Empower, DIRx (licences not yet independently verified by us).

Advantages and limitations

Evidence ledger

Every material claim on this page traces to a source, a capture date and a verification status.

Alternatives to consider

Compare NexLife against Found · Oak Longevity · LillyDirect. For the full field, see best GLP-1 programs and most affordable compounded tirzepatide.

Provider response

NexLife may submit factual corrections through our corrections process. Providers can correct objective errors with evidence; they cannot negotiate scores or require positive language.

Annual cost calculation

Monthly figures are how this category markets itself. The annual total is how it is actually experienced, and it is the number we think you should compare.

What is included, and what is not

The phrase "all-inclusive" is used loosely across this industry. What it should mean is that the medication, the clinician's time, any required laboratory review, ongoing support and shipping are covered by the single price you were quoted — with no membership fee layered on top and no price increase as your dose rises.

Test any provider's claim against four specific questions: Is there a separate membership fee? Does the price change at higher doses? Are laboratory costs included or billed separately? Is shipping included, and is it expedited? A programme that answers "no, no, yes, yes" is genuinely all-inclusive. Most are not.

Cancellation, refunds and what happens if you stop

Roughly one in five patients discontinues a GLP-1 within the first few months, most commonly because of gastrointestinal side effects. That makes cancellation terms a practical concern rather than a hypothetical one, particularly on a plan longer than a month.

Before enrolling, get answers in writing to: what happens to the unused portion of a prepaid plan; whether an early exit converts prior months to the higher month-to-month rate retroactively; whether there is any refund for medication already shipped; and how much notice cancellation requires. Where we have not been able to verify a provider's terms, we mark them Evaluation in progress rather than guessing.

Questions to ask about the pharmacy

The pharmacy matters more than the telehealth brand on the front of the website. The telehealth company arranges the consultation; the pharmacy makes the medicine you inject.

1. Which specific pharmacy will fill my prescription? Not "our network" — the name of the facility.
2. Is it a 503A state-licensed pharmacy or a 503B FDA-registered outsourcing facility? These are different regulatory categories with different oversight, and a company can use both for different products.
3. In which state is it licensed, and can I look up the licence? State boards of pharmacy publish licensee databases.
4. What is the exact salt form and concentration? Semaglutide sodium and semaglutide acetate are not the same active ingredient as the semaglutide base in approved products, and the FDA has said they are not appropriate for compounding.
5. Is the vial single-dose or multi-dose? A multi-dose vial requires you to measure each dose yourself, which is the most common source of the dosing errors behind reported adverse events.
6. Will you provide a certificate of analysis?
7. Has the pharmacy received any FDA warning letter or state board action?

A provider that answers all seven in writing is demonstrating something real. A provider that will not name its pharmacy has given you an answer, whether it intended to or not.

How to verify any of this yourself

You should not take our word for a price, and you do not have to. Every figure here can be checked in a few minutes.

1. Go to the provider's own pricing page. Not a comparison site — the provider's. Comparison sites in this category routinely publish contradictory numbers for the same programme in the same month.
2. Find the ongoing price, not the headline. Look for the words "first month", "intro", "starting at" or "new patients". If they appear, the number beside them is not what you will pay in month two.
3. Add the membership. If the medication and the membership are billed separately, add them. That sum is your real monthly cost.
4. Ask what the highest dose costs. By email or chat, so you have it in writing.
5. Ask about early cancellation before you commit to a plan longer than a month.
6. Check the manufacturer. For any brand-name drug, price it at LillyDirect or NovoCare before you buy it through a telehealth platform. Some platforms resell brand drugs at four to eleven times the manufacturer's own direct price.

If a provider will not answer questions 4 or 5 in writing, that is itself information.

Evidence ledger

Limitations of this analysis

Every page on this site should tell you where it stops being reliable. This one stops here.

Prices decay quickly. This is the fastest-moving data we publish. Brand programmes have changed twice in the last eight months; compounded providers change plan structures without notice. Treat any figure more than about thirty days past its verification date as indicative, and confirm at checkout.

Competitor pricing is reported, not captured by us. We hold dated captures for brand pricing and for NexLife. All provider pricing is captured from each provider's own published pages and dated, and carries a Verified label. Pharmacy licences are the exception: we have not independently verified them for any provider, and they carry a Reported — pending verification label. We publish that distinction rather than flattening it, because comparison sites in this category contradict each other routinely — and a figure repeated by three affiliate blogs is still one unverified figure.

We have not audited pharmacy licences. Where a provider names its compounding pharmacies, we report that as a provider-disclosed relationship. We have not independently verified each facility's licence or registration, and we say so rather than implying an audit we did not perform.

Advertised availability is not your availability. Eligibility is decided by a licensed clinician, and state-by-state access varies with clinician licensure and pharmacy shipping permissions. No page can promise you a price you will actually be offered.

We are commercially funded. The publisher and certain principals have financial relationships with some of the providers listed here, and we may earn a commission from provider links. That is disclosed in the footer of every page. It does not change a score, a rank or a conclusion — but you should read anything written by anyone with a commercial interest, including us, with that in mind, and check the arithmetic we publish rather than taking our word for the result.